Artal Group’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-566,641
Closed -$3.35M 43
2024
Q2
$3.35M Hold
566,641
0.09% 66
2024
Q1
$4.03M Hold
566,641
0.1% 70
2023
Q4
$4.59M Hold
566,641
0.15% 55
2023
Q3
$3.49M Hold
566,641
0.15% 63
2023
Q2
$4.99M Buy
566,641
+381,679
+206% +$4.24M 0.15% 67
2023
Q1
$1.36M Hold
184,962
0.08% 87
2022
Q4
$1.5M Hold
184,962
0.08% 97
2022
Q3
$2.48M Hold
184,962
0.11% 83
2022
Q2
$3.02M Hold
184,962
0.16% 81
2022
Q1
$4.22M Buy
184,962
+125,000
+208% +$2.24M 0.18% 87
2021
Q4
$1.4M Hold
59,962
0.04% 134
2021
Q3
$3.53M Hold
59,962
0.08% 122
2021
Q2
$5.49M Hold
59,962
0.11% 114
2021
Q1
$8.06M Sell
59,962
-35,000
-37% -$4.22M 0.14% 109
2020
Q4
$10.5M Buy
94,962
+35,000
+58% +$3.78M 0.23% 86
2020
Q3
$5.68M Hold
59,962
0.14% 93
2020
Q2
$6.97M Sell
59,962
-19,664
-25% -$1.92M 0.2% 88
2020
Q1
$6.57M Sell
79,626
-20,873
-21% -$2.29M 0.28% 60
2019
Q4
$12.3M Sell
100,499
-12,963
-11% -$1.1M 0.47% 39
2019
Q3
$8.51M Hold
113,462
0.34% 55
2019
Q2
$7.64M Buy
+113,462
New +$12M 0.31% 64

Other funds holding HOOK

Artal Group's HOOK Position: Q3 2024 in Review

Artal Group sold out of HOOKIPA Pharma (HOOK) in Q3 2024, closing a stake of 566,641 shares — an estimated $3.35M sold.

Artal Group first reported a position in HOOK in Q2 2019 and held it in 21 quarters. The position peaked at $12.3M in Q4 2019. 35 funds tracked by Wall St. Rank hold HOOK as of Q3 2024.

  • Artal Group reported no remaining HOOKIPA Pharma position as of Q3 2024 after selling out during the quarter.
  • Artal Group sold 566,641 HOOKIPA Pharma shares in Q3 2024, an estimated $3.35M.
  • Artal Group first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 21 quarters.
  • Artal Group's HOOKIPA Pharma position peaked at $12.3M in Q4 2019.
  • 35 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2024.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.